CC-223 and Ketoconazole Drug-Drug Interaction Study

NCT01896323 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

14

Enrollment

INDUSTRY

Sponsor class

Conditions

Healthy Volunteers

Interventions

DRUG: CC-223
DRUG: Ketoconazole

Sponsor

Celgene